Evidence map›Paper›PMID 32617199›Full record

ArticleIEEE journal of translational engineering in health and medicine2020

Ultrasound-Based Attenuation Imaging for the Non-Invasive Quantification of Liver Fat - A Pilot Study on Feasibility and Inter-Observer Variability.

Daniel Jesper, Daniel Klett, Barbara Schellhaas, Lukas Pfeifer, Moritz Leppkes, Maximilian Waldner, Markus F Neurath, Deike Strobel

Open access · goldAbstract read
In one paragraph

Article in IEEE journal of translational engineering in health and medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Daniel JesperDepartment of Internal Medicine 1Erlangen University Hospital, FAU University of Erlangen-Nürnberg91054ErlangenGermany.
Daniel KlettDepartment of Internal Medicine 1Erlangen University Hospital, FAU University of Erlangen-Nürnberg91054ErlangenGermany.
Barbara SchellhaasDepartment of Internal Medicine 1Erlangen University Hospital, FAU University of Erlangen-Nürnberg91054ErlangenGermany.
Lukas PfeiferDepartment of Internal Medicine 1Erlangen University Hospital, FAU University of Erlangen-Nürnberg91054ErlangenGermany.
Moritz LeppkesDepartment of Internal Medicine 1Erlangen University Hospital, FAU University of Erlangen-Nürnberg91054ErlangenGermany.
Maximilian WaldnerDepartment of Internal Medicine 1Erlangen University Hospital, FAU University of Erlangen-Nürnberg91054ErlangenGermany.
Markus F NeurathDepartment of Internal Medicine 1Erlangen University Hospital, FAU University of Erlangen-Nürnberg91054ErlangenGermany.
Deike StrobelDepartment of Internal Medicine 1Erlangen University Hospital, FAU University of Erlangen-Nürnberg91054ErlangenGermany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Attenuation imaging is a novel, ultrasound-based technique to objectively detect and quantify liver steatosis. In this study, we evaluated the performance and inter-observer variability of attenuation imaging and compared it to a known quantification method of liver fat, the hepatorenal index (HRI). Two observers measured attenuation coefficients (AC) in an attenuation phantom, 20 healthy volunteers and 27 patients scheduled for biopsy for suspected diffuse liver disease. Results were compared with the HRI and histological findings. Both observers were blinded to the results of the biopsy and the measurements of the other observer. Our results showed that patients with moderate (S2, 33-66%) and severe fatty infiltration of the liver (S3, >66%) showed significantly higher ACs in comparison to patients with a liver fat fraction of less than 33% (S0/1). There was no significant difference in AC-values of patients with fatty infiltration of less than 5% (S0) and 5-32% (S1). In the Receiver Operating Characteristic (ROC)-analysis, the area under the curve (AUC)-values for the detection of moderate and severe steatosis were excellent at 0.98. Cut-off values were 0.64 dB/cm/MHz for the detection of S2- and 0.68 dB/cm/MHz for the detection of S3-steatosis. The inter-observer agreement of attenuation imaging was very good with an intraclass correlation coefficient (ICC) of 0.92 in patient and 0.96 in phantom measurements. The ICC decreased with depth in the phantom measurements. In summary, attenuation imaging showed very good inter-observer agreement and is a promising tool for the detection and quantification of moderate and severe hepatic steatosis.

Indexed as

Attenuation imagingfatty liverhepatic fathepatic steatosishepatorenal indexinter-observerliver steatosisNAFLDNASHultrasound

Identifiers

PMID32617199
PMCPMC7326151
OpenAlexW3035391032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.